| Literature DB >> 24714687 |
Stefan Wallner1, Margot Grandl1, Tatiana Konovalova1, Alexander Sigrüner1, Thomas Kopf1, Markus Peer1, Evelyn Orsó1, Gerhard Liebisch1, Gerd Schmitz1.
Abstract
BACKGROUND: Dysregulation of monocyte-macrophage differentiation is a hallmark of vascular and metabolic diseases and associated with persistent low grade inflammation. Plasmalogens represent ether lipids that play a role in diabesity and previous data show diminished plasmalogen levels in obese subjects. We therefore analyzed transcriptomic and lipidomic changes during monocyte-macrophage differentiation in vitro using a bioinformatic approach.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24714687 PMCID: PMC3979739 DOI: 10.1371/journal.pone.0094102
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Gene ontology (GO) enrichment analysis of primary monocyte-macrophage differentiation.
Normalized enrichment scores (NES) indicate the distribution of Gene Ontology categories across a list of genes ranked by hypergeometrical score (HGS). Higher enrichment scores indicate a shift of genes belonging to certain GO categories towards either end of the ranked list, representing up or down regulation (positive or negative values, respectively). Lipid related catergories are generally found to be shifted upwards.
Figure 2Schematic representation of fatty acid synthesis pathways.
Fatty acid synthesis in the differentiation of primary human monocytes shows an induction of enzymes involved in the synthesis of palmitate (FAS), desaturation (SCD, D5D and D6D) and elongation (ELOVL5 & 6). Blue indicates significantly downregulated transcript levels, upregulated transcripts are shown in red and unchanged levels or unknown regulation in shown in grey.
Figure 3Regulation of PE plasmalogens during monocyte-macrophage differentiation.
(A) Levels of total plasmalogens over thre course of 5 day primary monocyte macrophage differentiation. Individual PE plasmalogen species show specific changes during differentiation (B and C). Saturation specificity relative to day 0 is shown in panel (D).
Figure 4HL-60 model for monocyte and granulocyte differentiation.
PE plasmalogen species in an in vitro model of monocytes and granulocytes using HL-60 cells show higher levels of species containing highly unsaturated acyl residues (>4 double bonds) in monocytic differentiation and higher levels of less unsaturated species (<4 double bonds), mono- or saturated species in granulocytic differentiation.
Figure 5Partial least squares discriminant analysis (PLS/DA) during the course of primary monocyte-macrophage differentiation.
While latent variable LV1 is able to discriminate between days 0/1 and days 4/5 of differentiation, LV4 can differentiate between days 4 and 5.
Figure 6Molecular network graph of genes correlating to PE plasmalogens during primary monocyte-macropahge differentiation.
Plasmalogens are shown in the center (rectangles) and correlating transcripts are grouped around them (circles). Circle size represents the number of connected nodes, line width the strength of the correlation and color the tyoe of regulation (upregulated in red, downregulated in blue). Central key nodes can be identified that have a multitude of connections to other nodes.
Results of an in silico transcription factor binding motif analysis.
| Up-regulated genes | Down-regulated genes |
| GZF1 | CHCH |
| LXR | PPARG |
| TATA | HIF2A |
| IRF | ZBTB |
| ZNF148 | ELF ETS |
| ATF CREB | AP1 |
| TFE | ZFX |
| GKLF | FKLF |
| USF | CNOT3 |
| FOX | RNF96 |
| MYCMAX | |
| AHRARNTHIF | |
| E2F |
Motives that were enriched in the 1000 bp promoter region upstream of up-regulated lipid related genes are shown on the left, binding motives that were enriched in promoters of down regulated genes on the right and motifs that were associated with up- and down-regulated genes at the bottom. Abbreviations (as used in the Transfac database): AHRARNTHIF: aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator/hypoxia inducible factor, AP1: activator protein 1, AP2: activating protein 2, ATF CREB: activating transcription factor/cAMP response element binding, CHCH: Churchill, CNOT3: CCR4-NOT transcription complex subunit 3, E2F: E2F transcription factor, EGR: early growth response, ELF ETS: E74-like factor/E26 transformation-specific, FKLF: fetal β-like globin gene-activating Krüppel-like factor, FOX: forkhead box, GKLF: gut-enriched Krüppel-like factor, GZF1: GDNF-inducible zinc finger protein 1, HIF2A: hypoxia-inducible factor 2a, IRF: interferon regulatory factor, LXR: liver X receptor, MYCMAX: Myc/Max transcriptional complex, NFY: nuclear factor Y, p53: phosphoprotein p53, PPARG: peroxisome proliferator-activated receptor-gamma, RNF96: RING finger protein 96, SP1SP4: specificity protein 1 and 4, TATA: TATA box, TFE: Transcription Factor E (Family), USF: upstream transcription factor, ZBTB: zinc finger and BTB (broad complex, tramtrack, and bric-à-brac) domain-containing, ZFX: zinc finger X-chromosomal protein, ZNF148: zinc finger protein 148.